All Categories
Following a Europe-wide selection process, Alzchem Group AG has been awarded an investment grant of EUR 34.4 million by the EU Commission as part of the ASAP ("Act in Support of Ammuni-tion Production") funding instrument.
As part of their cooperation, Alzchem Group AG and Crearene AG announced in October 2023 that a clinical study on the use of creatine in dialysis treatments had been launched. The aim is to demonstrate the technical feasibility, patient safety and dose finding of creatine-based dialysis treatment solutions.
Alzchem Group AG, a vertically integrated specialty chemicals supplier with a leading market position in selected niche markets, can look back on a successful fiscal year 2023. Despite a persistently challenging environment, the company succeeded in significantly increasing all key earnings figures and at EUR 540.6 million (2022: EUR 542.2 million) maintaining Group sales almost at the previous year’s record level.
We present our newest product flyer with fresh design and detailed content on product qualities and applications.
Working at Alzchem means making a lasting contribution to the success of a medium-sized company with potential.
![[Translate to English:]](/fileadmin/_processed_/3/6/csm_DSCF8825_ohne_Ohrmarken_7d8b79a079.jpg "[Translate to English:]")
The pioneering product Eminex® has offered an innovative solution to almost completely eliminate greenhouse gas emissions from manure storage.
According to study results published in the journal "Nature Reviews Microbiology", at least ten percent of all infected people worldwide struggle with the long-term effects of a coronavirus infection.
We wish you a Happy New Year 2024, with lots of success, happiness and health!